Sutro Biopharma
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $14,809 | $8,520 | $25,706 | $13,008 |
Gross Profit | 14,809 | 8,520 | -36,314 | 11,247 |
EBITDA | -59,530 | -39,078 | -38,934 | -49,268 |
EBIT | -61,398 | -40,877 | -40,724 | -51,029 |
Net Income | -72,443 | -48,787 | -48,018 | -58,213 |
Net Change In Cash | 14,809 | 8,520 | 25,706 | 13,008 |
Free Cash Flow | -72,806 | -65,344 | 8,699 | -65,187 |
Cash | 190,304 | 174,579 | 90,788 | 65,218 |
Basic Shares | 76,829 | 82,043 | 81,224 | 61,457 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $62,043 | $153,731 | $67,772 | $61,880 |
Gross Profit | 62,043 | 146,915 | 59,484 | 52,107 |
EBITDA | -186,810 | -67,915 | -105,070 | -98,524 |
EBIT | -194,028 | -74,731 | -113,358 | -108,297 |
Net Income | -227,461 | -106,793 | -119,204 | -108,675 |
Net Change In Cash | 62,043 | 153,731 | 67,772 | 61,880 |
Cost of Revenue | -175,738 | |||
Free Cash Flow | -194,638 | -115,931 | -4,309 | -97,002 |
Cash | 190,304 | 69,268 | 47,254 | 30,414 |
Basic Shares | 76,829 | 60,163 | 50,739 | 46,119 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.63 |
2024-09-30 | -$0.49 |
2024-06-30 | -$0.59 |
2024-03-31 | -$0.95 |
